Circumvent C-L

PORCINE CIRCOVIRUS VACCINE, TYPE 2, KILLED BACULOVIRUS VECTOR, LAWSONIA INTRACELLULARIS BACTERIN

This product has been shown effective for the vaccination of healthy swine 3 weeks of age or older against disease caused by Porcine Circovirus Types 2a and 2d, and Lawsonia intracellularis. Duration of immunity for Porcine Circovirus Type 2d is at least 16 weeks. Duration of immunity for ileitis due to Lawsonia intracellularis is at least 20 weeks. Duration of immunity for Porcine Circovirus Type 2a has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov. Composition: This product contains a subunit vaccine based on Porcine Circovirus Type 2a.

Dose: Shake well. Warm the vaccine to room temperature immediately prior to administration. Using aseptic technique, administer a single 2.0 mL dose via intramuscular route. For advice on revaccination frequency, consult your veterinarian.

Cautions: Store in the dark at 2-8°C (35-46°F). Do not freeze. Do not mix with other products. This product has not been tested in pregnant animals. Use entire contents when first opened. Do not vaccinate within 60 days of slaughter. A significant number of pigs may experience transient swelling at the site of injection. The swelling should resolve without treatment in less than 29 days. Immediate systemic reactions have been observed in animals administered this product. Minimize pig handling and ensure proper ventilation prior to starting vaccination. If allergic reaction occurs, treat with epinephrine. Caution should be used to avoid injecting your own fingers, hands or other body parts. Accidental injection can cause serious local reactions. In case of human exposure, contact a physician.

Preservatives: Gentamicin and thimerosal

FOR ANIMAL USE ONLY

Intervet Inc. d/b/a Merck Animal Health, Omaha, NE, USA

VLN 165A/PCN 49R5.R0

1 800 521-5767 (USA)

1 866 683-7838 (Canada)

For patent information:

http://www.merck.com/product/patent/home.html

CPN: 1047594.0